Oxford Asset Management’s Cytek Biosciences CTKB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $43.1K | Sell |
12,673
-13,967
| -52% | -$47.5K | 0.02% | 479 |
|
|
2025
Q1 | $107K | Buy |
+26,640
| New | +$107K | 0.05% | 408 |
|
|
2024
Q4 | – | Sell |
-25,257
| Closed | -$140K | – | 482 |
|
|
2024
Q3 | $140K | Buy |
+25,257
| New | +$140K | 0.12% | 264 |
|
|
2024
Q2 | – | Sell |
-13,726
| Closed | -$92.1K | – | 309 |
|
|
2024
Q1 | $92.1K | Buy |
+13,726
| New | +$92.1K | 0.1% | 223 |
|